Literature DB >> 11149162

Dangerous and common drug interactions in patients with diabetes mellitus.

J R White1, R K Campbell.   

Abstract

As more medications are made available to the prescriber, the likelihood of drug interactions will increase. The number of drug interactions encountered by the provider treating the patient with diabetes has increased over the past few years because the number of medications used in the management of hyperglycemia has dramatically increased during that time. These interactions are complex but can be predicted.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11149162     DOI: 10.1016/s0889-8529(05)70164-x

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  6 in total

Review 1.  Mechanisms of hypoglycemia unawareness and implications in diabetic patients.

Authors:  Iciar Martín-Timón; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2015-07-10

2.  Patients' perceptions of pharmacist-managed diabetes services in the ambulatory care and community settings within Singapore.

Authors:  Melanie Yee Lee Siaw; Jing Heng Toh; Joyce Yu-Chia Lee
Journal:  Int J Clin Pharm       Date:  2018-01-20

3.  DMTO: a realistic ontology for standard diabetes mellitus treatment.

Authors:  Shaker El-Sappagh; Daehan Kwak; Farman Ali; Kyung-Sup Kwak
Journal:  J Biomed Semantics       Date:  2018-02-06

4.  Polypharmacy, potentially serious clinically relevant drug-drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life.

Authors:  Labib Al-Musawe; Carla Torre; Jose Pedro Guerreiro; Antonio Teixeira Rodrigues; Joao Filipe Raposo; Helder Mota-Filipe; Ana Paula Martins
Journal:  Pharmacol Res Perspect       Date:  2020-08

Review 5.  Exercise Testing in Individuals With Diabetes, Practical Considerations for Exercise Physiologists.

Authors:  Christophe Kosinski; Cyril Besson; Francesca Amati
Journal:  Front Physiol       Date:  2019-09-27       Impact factor: 4.566

6.  The Prevalence of Potential Drug-Drug Interactions in CKD-A Retrospective Observational Study of Cerrahpasa Nephrology Unit.

Authors:  Andleeb Shahzadi; Ikbal Sonmez; Cagla Kose; Burhaneddin Oktan; Selma Alagoz; Haktan Sonmez; Adil Hussain; Ahmet Gokhan Akkan
Journal:  Medicina (Kaunas)       Date:  2022-01-26       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.